Cel-Sci to submit plan to maintain Amex listing

New York, Jan. 25 - Cel-Sci Corp. said it plans to meet the Feb. 7 deadline for submitting a plan to the American Stock Exchange for maintaining its listing.

The plan will need to show how the company will comply with the exchange's requirements by March 20, according to an 8-K filing with the Securities and Exchange Commission. The plan must also be accepted as reasonable by the American Stock Exchange's listing qualifications department.

Cel-Sci is out of compliance with the listing standards because it had not filed its form 10-K annual report for the year ended Sept. 30, 2005 by Jan. 24.

Cel-Sci, with operations in Vienna, Va., and Baltimore, is a pharmaceutical company focused on new immune system-based treatments for cancer and infectious diseases.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.